Brokerages Set Danaher Corporation (NYSE:DHR) Target Price at $228.91

Danaher Corporation (NYSE:DHR) has earned a consensus recommendation of “Moderate Buy” from the twenty-five research firms that are covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation, eighteen have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $228.9130.

A number of research analysts have recently weighed in on DHR shares. UBS Group assumed coverage on shares of Danaher in a research note on Wednesday, September 9th. They set a “buy” rating and a $250.00 price objective for the company. Citigroup started coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. Royal Bank Of Canada boosted their price target on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. Finally, DZ Bank assumed coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective on the stock.

Danaher Price Performance

Danaher stock opened at $212.45 on Tuesday. Danaher has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm’s 50-day simple moving average is $203.84 and its 200 day simple moving average is $191.91. The firm has a market capitalization of $149.35 billion, a PE ratio of 37.74, a P/E/G ratio of 2.59 and a beta of 0.78.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.77 EPS. On average, equities research analysts predict that Danaher will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Wednesday, September 30th. Danaher’s dividend payout ratio is 28.42%.

Institutional Trading of Danaher

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Wellington Altus USA Inc. increased its holdings in shares of Danaher by 45.6% during the 2nd quarter. Wellington Altus USA Inc. now owns 198 shares of the conglomerate’s stock worth $38,000 after buying an additional 62 shares during the last quarter. Reynders McVeigh Capital Management LLC raised its position in shares of Danaher by 0.5% in the 2nd quarter. Reynders McVeigh Capital Management LLC now owns 212,366 shares of the conglomerate’s stock worth $40,451,000 after buying an additional 1,058 shares during the period. Marathon Wealth Advisors LLC boosted its holdings in Danaher by 1.7% in the second quarter. Marathon Wealth Advisors LLC now owns 9,837 shares of the conglomerate’s stock valued at $1,874,000 after acquiring an additional 167 shares during the last quarter. Bouchey Financial Group Ltd. boosted its holdings in Danaher by 11.3% in the second quarter. Bouchey Financial Group Ltd. now owns 1,454 shares of the conglomerate’s stock valued at $277,000 after acquiring an additional 148 shares during the last quarter. Finally, Sequoia Financial Advisors LLC grew its position in Danaher by 4.0% during the second quarter. Sequoia Financial Advisors LLC now owns 23,461 shares of the conglomerate’s stock valued at $4,469,000 after acquiring an additional 902 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher Corporation (NYSE:DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its businesses support pharmaceutical and biotechnology research, biomanufacturing, clinical laboratories and healthcare providers.

The company’s portfolio includes bioprocessing technologies, laboratory instruments, consumables, reagents and software. Key businesses include Cytiva, which provides biomanufacturing solutions; Beckman Coulter, which supplies laboratory diagnostics and automation systems; Leica Biosystems, which develops pathology products; and IDT, which provides genomic and nucleic acid products.